The sites of metastases of transitional cell carcinoma of the bladder
are nodes, liver, lung and bone, but the meningeal infiltration is rar
e. Therefore, one case of meningeal carcinomatosis is reported. After
cystectomy for an undifferentiated carcinoma of the bladder, the patie
nt received adjuvant chemotherapy. Three months after treatment comple
tion, symptoms of cerebellar ataxia occurred and gradually confusion a
ppeared. The initial cerebro spinal fluid showed clumps of malignant c
ells. The patient died 15 days after tile neurological symptoms occurr
ed. The clinical diagnosis of meningeal carcinomatosis is based on neu
rological manifestations at more than one level of the neuraxis. Sympt
oms may present simply as headache or confusion. Meningeal carcinomato
sis from urothelial cancer seems to show some specific features: poorl
y differentiated tumour and high frequency of cerebellar symptoms. Int
rathecal treatment essentially has a pain-effect. Mean survival time i
s as short as 20 weeks. The increasing incidence of this neurological
complication. in urothelial cancer does not only result from an increa
se in patient longevity but also from possible side-effects of chemoth
erapy, so as localized changes in blood-brain barrier permeability ind
uced by antineoplastic drugs. Therefore, we may wonder whether meninge
al carcinomatosis might not be regarded as an iatrogenic effect.